RecruitingNCT06366048

A Study on Relationship Between Resected Normal Liver Parenchymal Volume(RNLV)and Post-Hepatectomy Liver Failure (PHLF)

A Model Based on Resected Normal Liver Parenchymal Volume(RNLV)to Predict the Risk of Post-Hepatectomy Liver Failure (PHLF)


Sponsor

National Natural Science Foundation of China

Enrollment

1,600 participants

Start Date

Dec 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The post-hepatotectomy liver failure (PHLF) is still the most worrisome complication of hepatic resection. Surgeons have always been making efforts to preoperatively predict PHLF using kinds of techniques, scoring systems, and variables. The investigators of this study tried to create an individual predictive model based on the variable, resected normal parenchymal volume (RNLV), then assessing the performance and value of the model in clinical practice.


Eligibility

Inclusion Criteria3

  • selective hepatectomies;
  • histologically confirmed as HCC and ICC
  • complete and accessible data

Exclusion Criteria6

  • any history of Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)
  • any history of portal vein embolism (PVE)
  • any history of tumor rupture
  • emergency surgery
  • pathologically diagnosed with neither HCC nor ICC
  • concomitant resection of gastrointestinal organs, spleenectomy or other organs

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTthe different definitions of PHLF according to 50-50 criteria and ISGLS criteria

Our study respectively defined the PHLF according to the 50-50 criteria and the ISGLS criteria in literature review.


Locations(3)

Mengchao Hepatobiliary Hospital of Fujian Medical University

Fujian, Shanghai Municipality, China

The Third Affiliated Hospital of Naval Medical University

Shanhai, Shanghai Municipality, China

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen, Mengchao Hepatobiliary Hospital of Fujian Medical University

Shenzhencun, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06366048


Related Trials